MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies ...

SAN FRANCISCO--(BUSINESS WIRE)--MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that ...

SANTA BARBARA, Calif. & BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--Miltenyi Biotec announced today that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and ...

Biomedical and clinical research company Miltenyi Biotec says that it has fully restored systems after a malware attack that took place last month and affected the firm's global IT infrastructure.

For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to ...

GlaxoSmithKline (GSK) and Miltenyi Biotech said they will partner to develop new cell and gene therapies through a collaboration whose value was not disclosed. The collaboration is designed to combine ...

(RTTNews) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the Court's ...

Miltenyi Biotec announced that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and commercializing microchip-based cell sorting systems using fully-closed ...

The tumor microenvironment (TME) is a complex biological network. Understanding interactions within the TME is a crucial step toward effective cancer therapy development. In this webinar, we present ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...